Long-term survival outcomes from a phase II trial of perioperative capecitabine plus oxaliplatin for advanced gastric cancer with extensive lymph node metastases: OGSG 1701

Shunji Endo, Yutaka Kimura, Naotoshi Sugimoto, Ryohei Kawabata, Atsushi Takeno, Shigeyuki Tamura, Jin Matsuyama, Masato Nakamura, Hiroki Takeshita, Motohiro Imano, Atsushi Yasuda, Hironaga Satake, Shogen Boku, Masahito Kotaka, Tomohira Takeoka, Yukinori Kurokawa, Toshimasa Tsujinaka, Toshio Shimokawa, Taroh Satoh